Allergy & Asthma Network
banner
allergyasthmahq.bsky.social
Allergy & Asthma Network
@allergyasthmahq.bsky.social
110 followers 91 following 300 posts
🌟 Allergy & Asthma Network unites and advocates on behalf of 60 million Americans with #asthma 😷, #allergies 🤧 and related conditions. Learn more ⬇️ AllergyAsthmaNetwork.org
Posts Media Videos Starter Packs
This research reinforces the power of early education and prevention in reducing food allergies which a major step forward for public health and families everywhere.

Watch the full interview here: mms.tveyes.com/PlaybackPort...
TVEyes Media Monitoring Suite - [Transcript]
mms.tveyes.com
Allergy & Asthma Network National Spokesperson, Dr. Purvi Parikh shared her insights on early introduction during the segment noting, “Give a small amount, and if they do well, continue to give it and slowly increase the amount every day.”
TVEyes Media Monitoring Suite - [Transcript]
mms.tveyes.com
A new CBS New York segment showcased encouraging findings highlighting a 43% decline in peanut allergies among children. Experts credit this to updated national guidance recommending that parents introduce peanut-containing foods to babies between 4 and 6 months of age.
Breathing is automatic, until it isn’t. That’s where respiratory therapists step in. During #RCWeek25, we invite our community to celebrate these highly trained, often unsung healthcare heroes. Thank an RT today, because they’ve likely helped someone you love.

AllergyAsthmaNetwork.org for more.
💊 Turning 65 or have a disability? You may qualify for Medicare, including Part D for prescription drug coverage. Many asthma, allergy, & eczema meds are included. Review your plan during Open Enrollment allergyasthmanetwork.org/health-insur...
Today is #MastCellDiseaseAwarenessDay! 💜
Learn how to manage triggers, explore treatment options & find support at MastCell.info.
Empower yourself with trusted resources.
This milestone broadens treatment options for people living with this chronic condition and reflects continued progress in advancing care for chronic respiratory conditions.

Read the full press release here: www.astrazeneca-us.com/media/press-...
TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps
www.astrazeneca-us.com
Congratulations to AstraZeneca and Amgen on the FDA approval expanding TEZSPIRE® (tezepelumab-ekko) to treat adults and adolescents with chronic rhinosinusitis with nasal polyps (CRSwNP).
TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps
www.astrazeneca-us.com
🌟 October is Health Literacy Month! 🌟 Allergy & Asthma Network is committed to providing clear, easy-to-understand resources for managing asthma, allergies, and eczema. Let’s work together to close the health literacy gap! 💙 #HealthLiteracyMonth #Asthma #Allergy #Eczema
Leading up to #COPD Awareness Month, COPD Action Alliance has released a new white paper: “COPD in America and the Road to Better Care.” The white paper is a valuable resource for COPD education and advocates for policymakers to support those affected. copdactionalliance.org/project_cate...
Papers | COPD Action Alliance
copdactionalliance.org
✅ Explore the latest research and treatments
✅ Learn strategies for schools and communities
✅ Hear powerful patient stories
✅ Engage in interactive discussions on policy + advocacy

This is your chance to connect, learn, and take action for the 28+ million people living with asthma.
USAsthma Summit is Friday, Nov. 7: Register Now  - Allergy & Asthma Network
Hear from national experts on how to improve asthma care and treatment at the 11th annual USAsthma Summit, Friday, Nov. 7, in Orlando, Florida.
allergyasthmanetwork.org
🌟 “The summit isn't just about giving out information, it's designed to be interactive. So you can ask questions, share your perspective, and leave with tools and connections to make a difference in your communities.” – Sherrina Gibson
Dr. Gardner’s work reinforces our mission to ensure that patient voices drive research and care decisions across allergic and dermatologic diseases.

Read the full systematic review here: doi: 10.1001/jamadermatol.2025.3663

#Research #ChronicUrticaria #Dermatology
The paper, “Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review”, highlights what matters most to patients in managing chronic urticaria, from rapid symptom relief to treatment safety and quality of life.
Congratulations to Allergy & Asthma Network’s Chief Research Officer, De De Gardner DrPH,RRT,FAARC,FCCP for contributing to a new publication in JAMA Dermatology!
3️⃣ Drug reactions are becoming more common as newer treatments like biologics and antibody therapies are used. Certain lab tests can help tell the difference between reaction types and guide care.
Did you miss our most recent webinar, ‘Drug Allergies: Diagnosis, Treatment, and Prevention '?

Here are some of the main takeaways:
1️⃣ Evaluating drug allergies takes a careful, step-by-step approach. Doctors look at a patient’s history, symptoms, and test results to make the right diagnosis.
Here’s what they cover:
💻 What telehealth is and how it works
🏥 When virtual visits work best
🧪 How lab work, prescriptions, and remote tools fit into virtual care
🔐 How your privacy is protected during online visits
How Telehealth Works for Food Allergy Care - Allergy & Asthma Network
In this podcast, explore how telehealth can help you manage allergies from home with easy and fast care through your phone or computer.
allergyasthmanetwork.org
🎙 Can you manage allergies, asthma or eczema without going to the clinic? Telehealth might be the answer.

Dr. Jay Portnoy joins Kortney and Dr. Gupta in this episode as they explore how virtual allergy care works and how it’s making care more flexible.